If you're in the market for a new credit card and struggling to get approved, CNBC Select rounded up the easiest credit cards to get. (See our methodology for more information on how we choose the ...

Most additives are only permitted to be used in certain foods and are subject to specific quantitative limits, so it is important to note this list should be used in conjunction with the appropriate ...

Mike Randall is a former contributing writer for CardRates.com. He is an expert in credit and personal finance, having written on those topics in national publications for over a decade. During his ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

PACE, Fla. -- A new subdivision has been approved in Pace, where some residents say the infrastructure is already not keeping up with developments. Santa Rosa County commissioners approved the ...

U.S. President Donald Trump signs an executive order about tariffs increase in the Oval Office of the White House in Washington, D.C. Kevin Lamarque/Reuters President Donald Trump has announced ...

In the US prescribing information, where acoramidis is approved under the brand name Attruby™, the most common side effects were mild and included diarrhea and abdominal pain that were resolved ...

Thursday marks 27 years since the U.S. Food and Drug Administration approved the sale of Viagra, the nation’s first oral medication for what’s now commonly known as erectile dysfunction.

The Signal messaging app, where senior US officials exchanged military plans in a chat group that included a journalist, is an approved application, the White House said Wednesday. "First of all ...

The Food and Drug Administration on Wednesday approved the first treatment for the insatiable hunger associated with the rare disease Prader-Willi syndrome, a long-awaited decision that follows an ...

A former U.S. FDA employee said he and other agency reviewers were pressured to approve Humacyte's (NASDAQ:HUMA) Symvess, an artificial blood vessel, despite safety concerns. The implantable ...